Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

Panelists discuss how they assess the individual support needs of patients diagnosed with diffuse large B-cell lymphoma or follicular lymphoma and describe an ideal model for industry-provided support services for these patients.

EP: 1.Challenges at Diagnosis: Navigating the Emotional and Physical Realities of DLBCL and FL

EP: 2.Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care

Now Viewing

EP: 3.Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

EP: 4.Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

EP: 5.Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

Video content above is prompted by the following:

How do you assess the individual support needs of each patient when they are diagnosed with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL)?
In a perfect world, describe what industry-provided support services look like for patients diagnosed with DLBCL and FL.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!